Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?
On September 22, Truist analyst Danielle Brill identified a “significant positive readthrough” for Maze Therapeutics, Inc.
Maze Therapeutics Inc. (MAZE)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 3,732,569 | $111,379,859 | +8% | 1.62% |
| 2. | Logos Capital Arsani William | 1,935,000 | $57,740,400 | +57% | 2.49% |
| 3. | A16z Capital Management Marc Andreessen And Ben Horowitz | 1,702,225 | $50,794,394 | 0.36% | |
| 4. | Braidwell LP Alex Karnal | 1,140,040 | $34,018,794 | 1.26% | |
| 5. | Farallon Capital Thomas Steyer | 1,107,814 | $33,057,170 | +198% | 0.15% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.02 | 31,908 | $862,186.07 | 191,447 | 2026-10-01 | Filing | |
| $27.02 | 2,593 | $70,073.49 | 15,558 | 2026-10-01 | Filing | |
| $26.93 | 16,141 | $434,743.31 | 0 | 2026-10-01 | Filing | |
| $27.06 | 7,500 | $202,920.75 | 32,316 | 2026-09-29 | Filing | |
| $26.22 | 9,705 | $254,501.98 | 0 | 2026-09-04 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 57,125 | $1,552,658 | 0.03% | |
| 2. | 327 | $8,888 | 0% | |
| 3. | 261 | $7,094 | 0% | |
| 4. | 202 | $5,490 | 0% | |
| 5. | 158 | $4,294 | 0% |
News See All
8 Oversold Stocks to Buy Right Now
In this article, we will discuss the 8 Oversold Stocks to Buy Right Now.
10 Oversold Small Cap Stocks to Buy Now
In this article, we will take a look at some of the most oversold small-cap stocks that currently offer attractive upside to investors. On April 18, stocks in the U.S.
Truist Updates Maze Therapeutics, Inc. (MAZE) Model for Share Count and Warrant Impact
We recently compiled a list of the 8 Oversold Biotech Stocks to Invest In Now. Maze Therapeutics, Inc. is one of the oversold stocks on our list.
8 Oversold Biotech Stocks to Invest In Now
In this article, we will be taking a look at the 8 Oversold Biotech Stocks to Invest In Now. On February 5, J.P.
8 Most Oversold Strong Buy-Rated Stocks to Invest In
In this article, we will look at the 8 Most Oversold Strong Buy-Rated Stocks to Invest In. Oversold stocks are getting a fresh look in 2026, but not simply because they are down.
Maze Therapeutics, Inc. (MAZE): A Bull Case Theory
We came across a bullish thesis on Maze Therapeutics, Inc. on deep market scan subreddit by retroviber. In this article, we will summarize the bulls’ thesis on MAZE.
Hedge Fund Resource Center